Prognosis
Gilead Drug to Undergo Human Trials in China to Cure Coronavirus
- Remdesivir being used on patients as there’s no approved drug
- China allows conditional approval of drugs if found effective
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
China has kick-started a clinical trial to speedily test a drug for the novel coronavirus infection as the nation rushes therapies for those afflicted and scours for vaccines to protect the rest.